Topic Archives: Nuplazid
-
-
FDA Rejects Nuplazid Application for Treatment of Alzheimer’s Disease Psychosis
The agency said more clinical trials would be required showing clearer results before it could approve Nuplazid to treat Alzheimer's disease psychosis.
-
ISMP Report Questions Nuplazid Safety, FDA Approval And Lack Of Warnings
-
Nuplazid Safety Risks May Lead FDA To Re-Review New Medication, Gottlieb Tells Senate
-
Nuplazid Problems Linked To Hundreds Of Patient Deaths: Report
-
Nuplazid Side Effects May Increase Parkinson’s Disease Hallucination Risks, ISMP Report Warns